Life-Threatening Bleeding in Patients Presenting to the ED: Treatment of Critically-Ill and Critically-Injured Patients - Day 2

 

EMCreg

 

Day 2
Thursday, May 16th, 2019
12:00 p.m. – 1:00 p.m.
Grand Ballroom D
**Lunch Provided**

Faculty

Pollack

Charles V. Pollack, Jr., MA, MD - Thomas Jefferson University, Philadelphia, PA - Appropriate therapy for the patient presenting to the ED with severe bleeding from vitamin K antagonists, Factor IIa inhibitor, or Factor Xa inhibitors.
Disclosures: Grants/Research Support Recipient: Boehringer Ingelheim, Janssen Pharmaceuticals, Portola Pharmaceuticals, Daiichi-Sankyo, CSL Behring.   


KnightWilliam A. Knight, IV, MD - University of Cincinnati EM/Critical Care - The ED management of the anticoagulated patient with GI bleeding and mucosal bleeding.
Disclosures: No relevant relationships

Kreitzer

Natalie E Kreitzer, MD - University of Cincinnati EM/Critical Care - Critical Care management of intracranial and intraspinal bleeding in the anticoagulated patient.
Disclosures: Consulting: GLC Consulting

SaraniBabak Sarani, MD, FACS - George Washington University, Trauma Surgery/Critical Care - Critical Care management of the anticoagulated trauma patient as well as patients on oral anticoagulants presenting to the ED requiring an emergent operation. 
Disclosures: Consulting: Portola Pharmaceuticals
Gibler

W. Brian Gibler, MD - University of Cincinnati (Moderator)
Disclosures: Advisory Board: AstraZeneca, Entegrion; Shareholder: MyocardioCare, Entegrion


This symposium will emphasize treatment of severe bleeding in anticoagulated patients in the Emergency Department and Critical Care environments. This is the 2nd hour of a 2-hour symposium. This hour includes four (4) ten (10) minute presentations followed by a 20-minute panel discussion and Q & A with attendees. 

Learning Objectives:

Emergency Physician attendees will able to DESCRIBE for the anticoagulated patient:

  • Anticoagulant therapy including warfarin, Factor Xa and Factor IIa inhibitors and the reversal agents for these patients in the ED and critical care environments
  • The treatment of severe gastrointestinal and mucosal bleeding
  • Management of intracranial and intraspinal bleeding in the critical care environment
  • The treatment of the trauma patient and the preparation of the trauma and surgical patient for the operating room

Accreditation Statement:

The University of Cincinnati College of Medicine Office of Continuing Medical Education is accrediting this 1-hour symposium for a total of 1 hour of Category 1 ACCME credit.